Raised to Date: Raised: $359,340
Rolling Commitments ($USD)
Do you, or does someone you know (and sleep with), snore? Are you tired of being woken up by chainsaw rumbles each night? If this sounds like you, then Zyppah could be the investment you’ve been waiting for. Zyppah is an anti-snoring device that will help you finally get some sleep again -- without those earthquake-like snoring interruptions.
Zyppah is here to help with your snore. It’s an oral hybrid mouthpiece that combines a patented tongue strap, called the Tongue Elastic, with traditional mouthpiece technology. The strap supports the tongue and keeps it from falling backwards into your airway, while the traditional technology brings the jaw forward. The best part? For the majority of clients, it’s not only comfortable, but it completely eliminates snoring -- even within the first night of use! Zyppah is the only hybrid mouthpiece of its kind in the US, and right now they are available to buy online. However, Zyppah anticipates FDA approval for over-the-counter sales in the next year, which means the produce would be sold in places like Amazon, Costco, and Walmart. So far, the company’s sold almost 140,000 units and collected $13M in revenue in 2017, and they have more than 20,000 unique visitors to their site per week. The device is made entirely in the US for $18 and retails for $100.
The Bottom Line:
100 million Americans snore a year, and 30-40 million of them develop sleep apnea. Zyppah can help these people (and their partners!) find the much-needed sleep they deserve. If they can capture even 10% of the snoring market, that would lead to 10 million appliances sold and $1B in sales. Zyppah can help you turn a profit….and sleep soundly while doing so.